Mass Balance Study of [14C] Flonoltinib Maleate
Clinical trial NCT07612306 · COMPLETED
Trial details
- NCT number
- NCT07612306
- Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2026-07-25
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.